Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Steven Roblin
Observed name:
Roblin, Steven
Institution:
Alnylam Pharmaceuticals (United States)
Observed institutions:
Alnylam Pharmaceuticals (United States),
University of Toronto,
Hospital for Sick Children,
Saint Luke's Hospital
OpenAlex ID:
A5066558790
Aryl Hydrocarbon Receptor-Dependent Induction of Flavin-Containing Monooxygenase mRNAs in Mouse Liver
2008
·
Trine Celius
, Steven Roblin
, et al.
·
Drug Metabolism and Disposition
·
55
Aryl Hydrocarbon Receptor Splice Variants in the Dioxin-Resistant Rat: Tissue Expression and Transactivational Activity
2007
·
Ivy D. Moffat
, Steven Roblin
, et al.
·
Molecular Pharmacology
·
30
AH receptor antagonist inhibits constitutive CYP1A1 and CYP1B1 expression in rat BP8 cells
2004
·
Steven Roblin
, Allan B Okey
, et al.
·
Biochemical and Biophysical Research Communications
·
22
Systemic Manifestations and Mortality Risk in Transthyretin V142I Variant Carriers
2026
·
Konstantinos Sideris
, Tyler J. Nelson
, et al.
·
JACC CardioOncology
·
3
Realizing the therapeutic potential of rapid knockdown of transthyretin via RNA interference in transthyretin amyloidosis
2025
·
Martha Grogan
, Farooq H. Sheikh
, et al.
·
Molecular Therapy — Nucleic Acids
·
3
Risk of Systemic Manifestations in Homozygous Carriers of the Transthyretin V142I Variant: A Million Veteran Program Analysis
2025
·
Konstantinos Sideris
, Tyler J. Nelson
, et al.
·
Journal of the American Heart Association
·
1
Clinical Manifestations In Homozygous Carriers Of The Transthyretin V142I Variant: A The Million Veteran Program Analysis
2026
·
Konstantinos Sideris
, Tyler J. Nelson
, et al.
·
Journal of Cardiac Failure
Impact of patisiran on polyneuropathy of hereditary transthyretin amyloidosis in patients with a V122I or T60A variant: a phase IV multicenter study
2025
·
Yessar Hussain
, Saurabh Malhotra
, et al.
·
Annals of Medicine
PDF
Abstract 4143840: Transthyretin V142I Genetic Variant and Heart Failure Risk: A Multi-Institutional Analysis of US Million-Veteran Program (MVP)
2024
·
Konstantinos Sideris
, Lina Brinker
, et al.
·
Circulation
A unified analysis of the impact of rapid TTR knockdown by RNAi therapeutics across transthyretin-mediated (ATTR) amyloidosis studies PC109 (#182)
2024
·
Martha Grogan
, Farooq Sheikh
, et al.
Effect of Rnai on Cardiomyopathy and Polyneuropathy Outcomes in Patients With V122i Variant Hereditary Transthyretin-mediated (hattr or Attrv) Amyloidosis
2023
·
Brett Wesley Sperry
, Dianna Quan
, et al.
·
Journal of the American College of Cardiology
The aryl hydrocarbon receptor: Impact of structural variation of the transactivation domain and interaction with a transcriptional repressor
2008
·
Roblin, Steven
·
TSpace (University of Toronto)
Show more works
View as search
Works count:
13
Citation count:
114
H-index:
3
I10-index:
3
Year
Topic
Type